Renaissance Technologies (RenTech)'s DYN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 533,600 shares of Dyne Therapeutics, Inc. (DYN) worth $9.67 M, representing 0.02% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in DYN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 345,500 shares. Largest reduction occurred in Q3 2024, reducing 126,000 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Dyne Therapeutics (DYN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Dyne Therapeutics (DYN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +62,955 | Add 13.38% | 533,600 | $18.13 |
| Q4 2025 | +125,145 | Add 36.22% | 470,645 | $19.56 |
| Q3 2025 | +345,500 | New Buy | 345,500 | $12.65 |
| Q3 2024 | -126,000 | Sold Out | 0 | $0.00 |
| Q2 2024 | +126,000 | New Buy | 126,000 | $35.29 |
| Q2 2023 | -73,300 | Sold Out | 0 | $0.00 |
| Q1 2023 | -34,400 | Reduce 31.94% | 73,300 | $0.01 |
| Q4 2022 | +2,800 | Add 2.67% | 107,700 | $0.01 |
| Q3 2022 | +13,700 | Add 15.02% | 104,900 | $12.70 |
| Q2 2022 | +48,500 | Add 113.58% | 91,200 | $6.88 |
| Q1 2022 | -25,800 | Reduce 37.66% | 42,700 | $9.65 |
| Q4 2021 | -72,000 | Reduce 51.25% | 68,500 | $11.88 |
| Q3 2021 | +140,500 | New Buy | 140,500 | $16.24 |
Renaissance Technologies (RenTech)'s Dyne Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Dyne Therapeutics, Inc. (DYN) in Q3 2021, acquiring 140,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Dyne Therapeutics, Inc. (DYN) for 13 quarters since Q3 2021.
Renaissance Technologies (RenTech)'s largest addition to Dyne Therapeutics, Inc. (DYN) was in Q3 2025, adding 345,500 shares worth $4.37 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 533,600 shares of Dyne Therapeutics, Inc. (DYN), valued at approximately $9.67 M.
As of the Q1 2026 filing, Dyne Therapeutics, Inc. (DYN) represents approximately 0.02% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Dyne Therapeutics, Inc. (DYN) was 533,600 shares, as reported at the end of Q1 2026.